Compare, Analyse Dishman Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ACTAVIS (US) - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DISHMAN PHARMA   ACTAVIS
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ACTAVIS
Dec-18
DISHMAN PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs37413,771-   
Low Rs1299,238-   
Sales per share (Unadj.) Rs197.83,378.1-  
Earnings per share (Unadj.) Rs21.2-1,088.1-  
Cash flow per share (Unadj.) Rs34.7356.0-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs179.913,933.1-  
Shares outstanding (eoy) m80.69332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.4 37.4%   
Avg P/E ratio x11.9-10.6 -112.2%  
P/CF ratio (eoy) x7.232.3 22.4%  
Price / Book Value ratio x1.40.8 169.4%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3063,826,440 0.5%   
No. of employees `0000.816.9 4.9%   
Total wages/salary Rs m5,3550-   
Avg. sales/employee Rs Th19,252.766,482.9 29.0%   
Avg. wages/employee Rs Th6,459.50-   
Avg. net profit/employee Rs Th2,064.1-21,414.2 -9.6%   
INCOME DATA
Net Sales Rs m15,9611,123,561 1.4%  
Other income Rs m26521,486 1.2%   
Total revenues Rs m16,2261,145,047 1.4%   
Gross profit Rs m4,10329,443 13.9%  
Depreciation Rs m1,091480,298 0.2%   
Interest Rs m94464,836 1.5%   
Profit before tax Rs m2,334-494,204 -0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0126,042 0.0%   
Tax Rs m624-6,263 -10.0%   
Profit after tax Rs m1,711-361,899 -0.5%  
Gross profit margin %25.72.6 981.0%  
Effective tax rate %26.71.3 2,108.7%   
Net profit margin %10.7-32.2 -33.3%  
BALANCE SHEET DATA
Current assets Rs m11,018460,826 2.4%   
Current liabilities Rs m9,517407,662 2.3%   
Net working cap to sales %9.44.7 198.7%  
Current ratio x1.21.1 102.4%  
Inventory Days Days11020 564.2%  
Debtors Days Days3566 52.5%  
Net fixed assets Rs m16,304127,181 12.8%   
Share capital Rs m1610-   
"Free" reserves Rs m12,9070-   
Net worth Rs m14,5164,634,163 0.3%   
Long term debt Rs m4,1891,631,857 0.3%   
Total assets Rs m29,8057,244,252 0.4%  
Interest coverage x3.5-6.6 -52.4%   
Debt to equity ratio x0.30.4 82.0%  
Sales to assets ratio x0.50.2 345.3%   
Return on assets %8.9-4.1 -217.3%  
Return on equity %11.8-7.8 -150.9%  
Return on capital %17.5-4.8 -362.1%  
Exports to sales %24.80-   
Imports to sales %3.70-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,786401,406 0.7%  
From Investments Rs m-1,529220,520 -0.7%  
From Financial Activity Rs m-941-688,933 0.1%  
Net Cashflow Rs m316-66,672 -0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.17 Rs / USD

Compare DISHMAN PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DISHMAN PHARMA With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  TORRENT PHARMA  BIOCON   GLENMARK PHARMA  



Today's Market

Sensex Trades Marginally Lower; Asian Paints & Tata Steel Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 106 points while the NSE Nifty is trading down by 25 points.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth? (The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Your Safe Income Options for 2020 (Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
A Simple Test to Find out If a Stock Has 100x Potential
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 8-QTR ANALYSIS

COMPARE DISHMAN PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS